An Elevated FSH level
FSH, or Follicle Stimulating Hormone, is a hormone that is produced and released by the pituitary gland in the brain and it stimulates the ovaries to develop follicles, ripen the eggs and eventually release the eggs. FSH fluctuates from cycle to cycle but in young women with good ovarian function, FSH level is normally low and the fluctuation is minimal.
As a woman ages, her ovaries produce less oestrogen and the brain tries to jump-start the process by sending more FSH into the bloodstream. The higher level of FSH prompts the ovaries to recruit more than the dozen follicles, typically developed, to produce oestrogen for the next cycle.
During the perimenopause period, while there may be regular cycles, the follicles’ response to FSH becomes unpredictable and oestrogen levels can be unusually high and low with a wide variety of symptoms.
FSH fluctuation becomes greater and the maximum reading gets higher and remains high until finally the woman enters menopause at an average age of 51 following 10 to 15 years in the transition period.
FSH is often used as a gauge of ovarian reserve
A baseline FSH blood test on day 2 or 3 of the menstrual cycle is expected to be below 10 iu/l in women with reproductive potential, FSH levels of 10-12 iu/l are considered borderline.
|In general, under 6 is excellent, 6-9 is good, 9-10 fair, 10-13 diminished reserve, 13+ very hard to stimulate.
In PCOS testing, the LH:FSH ratio may be used in the diagnosis. The ratio is usually close to 1:1, but if the LH is higher, it is one possible indication of PCOS.
High FSH is an extremely frustrating diagnosis
Finding FSH levels in the menopausal range is very common among our patients and it is a difficult issue to deal with as high FSH indicates a poor ovarian reserve with the number of eggs left in the ovaries declining and the woman is undergoing menopausal transition. As a consequence, the woman becomes progressively less fertile.
Many women with high FSH levels are told that there is nothing that can be done to help with this. They cannot even embark on IVF or IUI until their FSH drops to 11 or 12, the usual cut-off line, as they are more likely to be poor responders to fertility drugs. They are often advised to consider IVF with donor eggs. However, fertility drugs or hormonal replacement treatment do not address the cause for the failure of the ovaries.
Hormone Replacement Therapy using contraceptive pills or oestrogen replacement therapy can artificially suppress FSH and relieve symptoms but the use of an exogenous synthetic hormone can cause suppression of the natural hypothalamus-pituitary-ovarian axis feedback communication and does not necessarily improve a poor ovarian reserve or increase the chance of conception.
Most women with high FSH prefer a treatment that will restore their ovaries and hormonal system to fully functional health and will hopefully enable them to conceive with their own eggs and have their own genetic children.
Degree of Oestrogen deficiency
Symptoms of oestrogen deficiency often develop with high FSH in many, but not all, patients. The symptoms include night sweats; insomnia; headaches; restlessness; lethargy; short menstrual cycle with scanty bleeding; irregular periods; amenorrhea; early ovulation; anovulation; lack of cervical mucus; infertility. These symptoms may appear suddenly over a couple of months, or gradually over several years.
Link: premature ovarian failure
Seeing my female patients mostly in their late 30s and early 40s, when hormone regulation or steroid decline becomes a problem compounded with subtle metabolic changes, not only fertility issues, I often observe signs and symptoms of whole body transitions. From the mid 30s, it is not only circulating major hormones such as growth hormone, insulin, thyroid hormone, cortisol and sex steroids that undergo changes but the functions and sensitivities of many glands and tissue receptors decline. Changes in sex steroid levels during perimenopause are compounded by a lowered metabolic state with numerous repercussions in lowered cellular activities, adrenal gland compensation with stress response pathology, chronic inflammation, autoimmunity and coagulopathy (clotting disorders). The cell’s environment, the signals and substances and energy it receives is complex and its manifestations can be across the spectrum. When it comes to ovarian depletion, we see it as a continuum of impaired ovarian function rather than a dichotomous state. Everyone’s transition has different shades, therefore the assessment and the treatment should be individualized and multi-factored.